Results 181 to 190 of about 1,191,211 (370)
Advance directives in the intensive care unit of a tertiary cancer center
Michael S. Ewer, J Taubert
openalex +1 more source
Rejoinder to discussions on clustered encouragement designs with individual noncompliance: Bayesian inference with randomization, and application to advance directive forms [PDF]
Constantine Frangakis
openalex +1 more source
Ubiquitination of transcription factors in cancer: unveiling therapeutic potential
In cancer, dysregulated ubiquitination of transcription factors contributes to the uncontrolled growth and survival characteristics of tumors. Tumor suppressors are degraded by aberrant ubiquitination, or oncogenic transcription factors gain stability through ubiquitination, thereby promoting tumorigenesis.
Dongha Kim, Hye Jin Nam, Sung Hee Baek
wiley +1 more source
Discussion of 'Clustered encouragement designs with individual noncompliance: Bayesian inference with randomization, and application to advance directive forms' by Frangakis, Rubin and Zhou [PDF]
Els Goetghebeur
openalex +1 more source
Nuclear prothymosin α inhibits epithelial‐mesenchymal transition (EMT) in lung cancer by increasing Smad7 acetylation and competing with Smad2 for binding to SNAI1, TWIST1, and ZEB1 promoters. In early‐stage cancer, ProT suppresses TGF‐β‐induced EMT, while its loss in the nucleus in late‐stage cancer leads to enhanced EMT and poor prognosis.
Liyun Chen+12 more
wiley +1 more source
Breast cancer metastasis is associated with myeloid cell dysregulation and the lung‐specific accumulation of tumor‐supportive Gr1+ cells. Gr1+ cells support metastasis, in part, through a CHI3L1‐mediated mechanism, which can be targeted and inhibited with cargo‐free, polymeric nanoparticles.
Jeffrey A. Ma+9 more
wiley +1 more source
Factors That Influence Attitudes toward Advance Directives among Female Cancer Patients. [PDF]
Kim A, Kim K.
europepmc +1 more source
Advance Directives and Patient-Physician Communication [PDF]
Michael E. Hahn
openalex +1 more source
This study develops a semi‐supervised classifier integrating multi‐genomic data (1404 training/5893 validation samples) to improve homologous recombination deficiency (HRD) detection in breast cancer. Our method demonstrates prognostic value and predicts chemotherapy/PARP inhibitor sensitivity in HRD+ tumours.
Rong Zhu+12 more
wiley +1 more source